General Information
Revision date
2022-05-24
Product name
Desvenlafaxine Extended Release Tablets 25 mg, 50 mg and 100 mg
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
WARNING Short Term Harmful if swallowed Individuals taking monoamine oxidase (MAO) inhibitors should avoid exposure to this material. Long Term Repeat-dose studies in animals have shown a potential to cause adverse effects on liver. Known Clinical Effects Ingestion of this material may cause effects similar to those seen in clinical use including dizziness, insomnia, nausea, constipation, vomiting, dry mouth, nervousness, anxiety, tremors, impotence, abnormal dreams, abnormal ejaculation, and sweating. Signs and symptoms associated with non-fatal over dosage were drowsiness, vomiting, rapid heart rate, nausea, dizziness, agitation, and tremor.